Recent Trends For § 112 Challenges In PGRs - Kluwer Patent Blog

In recent years, the Court of Appeals for the Federal Circuit has invalidated or affirmed the invalidity of various biopharma patents under 35 U.S.C. § 112, which requires that a patent specification contain a written description of the invention...